Deborah Beyer, MD
Internal Medicine · Nashville, TNNPI 1316987654
Payments from drug & device makers
Across 664 payments — averaging $17.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$3K
- Pfizer$1K
- AbbVie$1K
- AstraZeneca$1K
- Amgen$1K
- Lilly USA, LLC$971
- plus $3K from 31 others
What the payments were for
- Food & beverage$11,370100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 162 | $2,711 |
| Pfizer | 94 | $1,383 |
| AbbVie(2 entities) | 76 | $1,282 |
| AstraZeneca | 59 | $1,160 |
| Amgen | 65 | $1,084 |
| Lilly USA, LLC | 53 | $971 |
| Merck | 16 | $283 |
| GSK | 17 | $278 |
| Sanofi-aventis U.S. LLC | 11 | $226 |
| Boehringer Ingelheim | 12 | $204 |
| Abbott | 10 | $184 |
| Biohaven Pharmaceutical Holding Company Ltd. | 12 | $183 |
| Exact Sciences | 10 | $166 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $157 |
| Esperion Therapeutics, Inc. | 6 | $129 |
| Novartis | 5 | $110 |
| Bayer | 5 | $109 |
| Johnson & Johnson | 6 | $108 |
| Sanofi Pasteur Inc. | 5 | $82 |
| Lundbeck LLC | 3 | $78 |
| Gilead | 4 | $68 |
| Kowa Pharmaceuticals America, Inc. | 4 | $64 |
| Amarin Pharma, Inc. | 3 | $60 |
| Hologic Inc | 1 | $51 |
| Eisai Inc. | 2 | $32 |
| Astellas Pharma US Inc | 1 | $28 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Cequr Corporation | 1 | $21 |
| Antares Pharma, Inc. | 1 | $19 |
| Amneal Pharmaceuticals LLC | 1 | $19 |
| Dynavax Technologies Corporation | 2 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Cranial Technologies, Inc | 1 | $15 |
| Therapeuticsmd, Inc. | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $13 |
| Hologic Sales And Service, LLC | 1 | $12 |
| Shire North American Group Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,370 in reported general payments places this provider in the 90th percentile of 2,216 internal medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 58 | $79,535 |
| FarxigaDapagliflozin Propanediol | 47 | $41,604 |
| EliquisApixaban | 47 | $37,415 |
| JardianceEmpagliflozin | 24 | $32,685 |
| XareltoRivaroxaban | 12 | $14,677 |
| MyrbetriqMirabegron | 16 | $14,069 |
| Breo ElliptaFluticasone/Vilanterol | 16 | $12,069 |
| TrulicityDulaglutide | 11 | $12,066 |
| PremarinEstrogens, Conjugated | 15 | $6,771 |
| VyvanseLisdexamfetamine Dimesylate | 14 | $5,406 |
| SynthroidLevothyroxine Sodium | 48 | $3,898 |
| Atorvastatin Calcium | 249 | $3,411 |
| Omeprazole | 193 | $2,829 |
| Losartan Potassium | 222 | $2,745 |
| Lisdexamfetamine Dimesylate | 11 | $2,714 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $2,711 | $79,53558 claims |
| PfizerEliquis, Premarin | $1,383 | $44,18662 claims |
| AstraZenecaFarxiga | $1,160 | $41,60447 claims |
| Boehringer IngelheimJardiance | $204 | $32,68524 claims |
| Johnson & JohnsonXarelto | $108 | $14,67712 claims |
| Astellas Pharma US IncMyrbetriq | $28 | $14,06916 claims |
| GSKBreo Ellipta | $278 | $12,06916 claims |
| Lilly USA, LLCTrulicity | $971 | $12,06611 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $157 | $5,40614 claims |
| AbbVieSynthroid | $1,282 | $3,89848 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $19 | $2,541211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,216 internal medicine providers in Tennessee.
Other internal medicine in Nashville
- John AndersonNashville$1.5M
- Nancy DavisNashville$985K
- Wayne RileyNashville$536K
- Paul FerrellNashville$413K
- Cyndya Shibao MiyasatoNashville$364K
- Hilary TindleNashville$337K
- Harvey BowlesNashville$203K
- Jay MontgomeryNashville$174K
- Temidayo AbeNashville$113K
- Nader BahriNashville$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.